... were found in 26/180 patients, and 3 out of these patients died because of massive, recurrent PE. No significant differences were found in age and sex distribution, or in the degree of deep vein thrombosis proximity between patients who did or did not develop recurrences. There were, however...

... streptokinase treatment, while it rarely took place in patients who did not receive either streptokinase or heparin and in those treated with streptokinase alone. The study of patients receiving heparin for deep vein thrombosis suggested that SPA may derive from adenosine diphosphate released from platelets...

...Giancarlo Agnelli; Stefano Radicchia; Giuseppe G. Nenci Postoperative deep vein thrombosis is usually asymptomatic so that pulmonary embolism is often the first clinical manifestation of venous thromboembolism. The diagnostic accuracy of impedance plethysmography, 125 I-fibrinogen leg scanning...

...Brownell Wheeler; Frederick A. Anderson, Jr. Clinical diagnosis of deep vein thrombosis (DVT) is unreliable, and treatment should not be undertaken without objective confirmation. The traditional ‘gold standard’ for the diagnosis of DVT has been venography, but ultrasonic imaging has now replaced...

... have demonstrated that low molecular weight heparins, that have improved pharmacologic and pharmacokinetic properties over standard heparin, are effective and safe in the treatment of deep vein thrombosis. Two large randomized clinical trials have shown the feasibility of the outpatient treatment...

...; 26 (Suppl 4): 379-387 PROLONGED PROPHYLAXIS AGAINST POSTOPERATIVE VENOUS THROMBOEMBOLISM. David Bergqvist. M.D.. Ph.D.. Professor of Vascular Surgery, University Hospital. Department of Surgery, S-751 85 Uppsala, Sweden. Key words: Deep vein thrombosis, postoperative thromboembolism, prolonged pro­...

...B. Boneu Besides low molecular weight heparins (LMWHs) a number of new antithrombotic agents have been evaluated mainly in the prevention of deep vein thrombosis (DVT) and, to a lesser extent, in the treatment of established DVT. They include the Pentasaccharide, a synthetic ultra LMWH, Dermatan...

...David Bergqvist Clinical diagnosis of deep vein thrombosis and pulmonary embolism is difficult. Therefore objective tests are necessary. This paper discusses the principal viewpoints on which criteria can be used for various tests and how new methods should be evaluated. 28 4 2009 ©...

... in the HR group in comparison with the LR group, and a strong decrease in protein C inhibitor in the early postoperative period was detected in all the groups. In spite of heparin prophylaxis, 2 HR patients were diagnosed as deep vein thrombosis (DVT) during the postoperative period. Both patients showed...

...) once daily for 5 weeks or placebo following a 1-week LMWH treatment (once daily). Bilateral phlebography was performed between days 33 and 35 or before if patients had clinical symptoms of deep vein thrombosis. A lung scan was performed in patients with clinical symptoms of pulmonary embolism. Levels...

...A.G.G. Turpie Venous thrombo-embolism is a common complication in patients with acute ischaemic stroke. Without prophylaxis, deep vein thrombosis occurs in 60-75% of patients with dense hemiplegia, usually in the paralyzed limb, and 1-2% suffer fatal pulmonary embolism. Orgaran (Org 10172, low...

... was significantly more effective in reducing the frequency of deep vein thrombosis without producing an increase in bleeding complications or other side effects. 28 4 2009 © 1992 S. Karger AG, Basel 1992 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication...

... Words. Heparin Low-molecular-weight heparin Deep vein thrombosis Anticoagulation Abstract. Heparin was a chance discovery made by a medical student who was searching for a clot-promoting activity in various tissue extracts and found an inhibitor of coagulation. It has taken 20 years from...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Deep vein thrombosis Heparin, low...

...Evald Johansson; Krister Forsberg; Hans Johnsson The rate of postoperative deep vein thrombosis was studied by the 125 I-fibrinogen method in 35 patients after total hip replacement. 12 out of 18 patients treated prophylactically with hydroxychloroquine sulfate developed deep vein thrombosis...

... of heparin. The incidence of deep vein thrombosis determined by the 125 I-fibrinogen test was 40 % in the first group, 50 % in the second group, and 5 % in the third group. The differences between the heparin group and the two other groups are statistically significant. No wound complication and no haematoma...

...David Bergqvist; Bengt Jönsson Several studies have demonstrated that prolongation of thromboprophylaxis after elective hip replacement significantly reduces the frequency of venographically demonstrated deep vein thrombosis. This paper reports an economic evaluation of prolonged prophylaxis...

... to in the content or advertisements. Deep vein thrombosis Low-molecular-weight heparin Thromboprophylaxis Chemotherapy Cancer Main Paper Haemostasis 1998;28(suppl 3):61 65 Ajay K. Kakkar Robin C.N. Williamson Department of Surgery, Imperial College School of Medicine, Hammersmith Hospital, London, UK...

...-weight heparins prevented subclinical deep vein thrombosis in ischaemic stroke, myocardial infarction and among elderly medical inpatients. Although it is likely that these drugs also prevent subclinical deep vein thrombosis after spinal cord injury or other major trauma, and when patients require...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 17 11 2004 Deep vein thrombosis Venous thromboembolism Low...